Literature DB >> 12367763

Human hereditary hepatic porphyrias.

Yves Nordmann1, Hervé Puy.   

Abstract

The human hereditary hepatic porphyrias are diseases due to marked deficiencies of enzymes in the heme biosynthetic pathway. Porphyrias can be classified as either hepatic or erythroid, depending on the major production site of porphyrins or their precursors. The pathogenesis of inherited hepatic porphyrias has now been defined at the molecular level. Some gene carriers are vulnerable to a range of exogenous and endogenous factors, which may trigger neuropsychiatric and/or cutaneous symptoms. Early diagnosis is of prime importance since it makes way for counselling. In this article we present an overview of recent advances on hepatic porphyrias: 5-aminolevulinic acid dehydratase deficiency porphyria, acute intermittent porphyria (AIP), porphyria cutanea tarda (PCT), hereditary coproporphyria (HC), and variegate porphyria (VP). Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12367763     DOI: 10.1016/s0009-8981(02)00276-0

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  13 in total

1.  Feline porphyria associated with anemia, severe hepatic disease, and renal calculi.

Authors:  Jonathan J Schnier; Paul Hanna
Journal:  Can Vet J       Date:  2010-10       Impact factor: 1.008

2.  A case of acute abdomen for the internist.

Authors:  Sergio Neri; Davide Pulvirenti; Tsami Aikaterini
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

3.  Psychosocial aspects of predictive genetic testing for acute intermittent porphyria in norwegian minors.

Authors:  Janice Andersen; Sverre Sandberg; Maalfrid Raaheim; Eva Gjengedal
Journal:  JIMD Rep       Date:  2011-06-22

4.  Structural basis of hereditary coproporphyria.

Authors:  Dong-Sun Lee; Eva Flachsová; Michaela Bodnárová; Borries Demeler; Pavel Martásek; C S Raman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-21       Impact factor: 11.205

Review 5.  Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias.

Authors:  Vaithamanithi-Mudumbai Sadagopa Ramanujam; Karl Elmo Anderson
Journal:  Curr Protoc Hum Genet       Date:  2015-07-01

6.  Dimethyl sulfoxide and ebselen prevent convulsions induced by 5-aminolevulinic acid.

Authors:  Carlos André Prauchner; Adriano Neujahr Agostini; Akemi Morimoto; Paula Rossini Augusti; Taís Cristina Unfer; Gilson Zeni; Carlos Fernando Mello; Tatiana Emanuelli
Journal:  Neurochem Res       Date:  2004-10       Impact factor: 3.996

7.  Mutational analysis of uroporphyrinogen III cosynthase gene in Iranian families with congenital erythropoietic porphyria.

Authors:  Meysam Moghbeli; Mahmood Maleknejad; Azadeh Arabi; Mohammad Reza Abbaszadegan
Journal:  Mol Biol Rep       Date:  2012-02-18       Impact factor: 2.316

Review 8.  Animal models for metabolic, neuromuscular and ophthalmological rare diseases.

Authors:  Guillaume Vaquer; Frida Rivière; Maria Mavris; Fabrizia Bignami; Jordi Llinares-Garcia; Kerstin Westermark; Bruno Sepodes
Journal:  Nat Rev Drug Discov       Date:  2013-03-15       Impact factor: 84.694

9.  Functional characterisation and transcriptional regulation of the KlHEM12 gene from Kluyveromyces lactis.

Authors:  Laura Núñez; Isabel González-Siso; Manuel Becerra; M Esperanza Cerdán
Journal:  Curr Genet       Date:  2004-07-15       Impact factor: 3.886

10.  N-alkylprotoporphyrin formation and hepatic porphyria in dogs after administration of a new antiepileptic drug candidate: mechanism and species specificity.

Authors:  Jean-Marie Nicolas; Hugues Chanteux; Valérie Mancel; Guy-Marie Dubin; Brigitte Gerin; Ludovicus Staelens; Olympe Depelchin; Sophie Kervyn
Journal:  Toxicol Sci       Date:  2014-06-27       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.